tiprankstipranks
Trending News
More News >
Addex Therapeutics Ltd (ADR) (ADXN)
:ADXN
US Market
Advertisement

Addex Therapeutics (ADXN) Financial Statements

Compare
73 Followers

Addex Therapeutics Financial Overview

Addex Therapeutics's market cap is currently $13.60M. The company's EPS TTM is $; its P/E ratio is 0.74; Addex Therapeutics is scheduled to report earnings on June 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueCHF 404.10KCHF 1.61MCHF 1.42MCHF 2.92MCHF 3.61M
Gross ProfitCHF -444.26KCHF -5.32MCHF -13.20MCHF -9.90MCHF -6.76M
Operating IncomeCHF -2.76MCHF -10.28MCHF -20.52MCHF -15.51MCHF -12.24M
EBITDACHF -4.65MCHF -10.23MCHF -20.23MCHF -14.94MCHF -12.41M
Net IncomeCHF 7.06MCHF -10.56MCHF -20.80MCHF -15.35MCHF -12.86M
Balance Sheet
Cash & Short-Term InvestmentsCHF 3.35MCHF 3.87MCHF 6.96MCHF 20.50MCHF 18.76M
Total AssetsCHF 10.68MCHF 4.64MCHF 8.28MCHF 22.54MCHF 20.18M
Total DebtCHF 41.99KCHF 344.34KCHF 373.13KCHF 482.01KCHF 567.40K
Net DebtCHF -3.30MCHF -3.52MCHF -6.58MCHF -20.00MCHF -18.13M
Total LiabilitiesCHF 1.00MCHF 3.50MCHF 3.37MCHF 5.61MCHF 5.57M
Stockholders' EquityCHF 9.68MCHF 1.15MCHF 4.91MCHF 16.93MCHF 14.61M
Cash Flow
Free Cash FlowCHF -5.37MCHF -8.00MCHF -16.44MCHF -14.74MCHF -12.24M
Operating Cash FlowCHF -5.37MCHF -7.99MCHF -16.44MCHF -14.71MCHF -12.18M
Investing Cash FlowCHF 4.65MCHF -6.84KCHF 2.97KCHF -30.31KCHF -59.41K
Financing Cash FlowCHF 104.92KCHF 5.26MCHF 3.10MCHF 16.40MCHF 46.40K
Currency in CHF

Addex Therapeutics Earnings and Revenue History

Addex Therapeutics Debt to Assets

Addex Therapeutics Cash Flow

Addex Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis